Global Alzheimers and Parkinsons Diseases Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Alzheimers and Parkinsons Diseases
    1.2 Classification of Alzheimers and Parkinsons Diseases by Type
        1.2.1 Overview: Global Alzheimers and Parkinsons Diseases Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Alzheimers and Parkinsons Diseases Revenue Market Share by Type in 2020
        1.2.3 Alzheimers
        1.2.4 Parkinsons
    1.3 Global Alzheimers and Parkinsons Diseases Market by Application
        1.3.1 Overview: Global Alzheimers and Parkinsons Diseases Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Global Alzheimers and Parkinsons Diseases Market Size & Forecast
    1.5 Global Alzheimers and Parkinsons Diseases Market Size and Forecast by Region
        1.5.1 Global Alzheimers and Parkinsons Diseases Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Alzheimers and Parkinsons Diseases Market Size by Region, (2016-2021)
        1.5.3 North America Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
        1.5.4 Europe Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
        1.5.6 South America Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Alzheimers and Parkinsons Diseases Market Drivers
        1.6.2 Alzheimers and Parkinsons Diseases Market Restraints
        1.6.3 Alzheimers and Parkinsons Diseases Trends Analysis
2 Company Profiles
    2.1 Hoffmann-La Roche
        2.1.1 Hoffmann-La Roche Details
        2.1.2 Hoffmann-La Roche Major Business
        2.1.3 Hoffmann-La Roche Alzheimers and Parkinsons Diseases Product and Solutions
        2.1.4 Hoffmann-La Roche Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Hoffmann-La Roche Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Alzheimers and Parkinsons Diseases Product and Solutions
        2.2.4 Novartis Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer Alzheimers and Parkinsons Diseases Product and Solutions
        2.3.4 Pfizer Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Pfizer Recent Developments and Future Plans
    2.4 Merck
        2.4.1 Merck Details
        2.4.2 Merck Major Business
        2.4.3 Merck Alzheimers and Parkinsons Diseases Product and Solutions
        2.4.4 Merck Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Merck Recent Developments and Future Plans
    2.5 Eli Lilly
        2.5.1 Eli Lilly Details
        2.5.2 Eli Lilly Major Business
        2.5.3 Eli Lilly Alzheimers and Parkinsons Diseases Product and Solutions
        2.5.4 Eli Lilly Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Eli Lilly Recent Developments and Future Plans
    2.6 Orion Pharma
        2.6.1 Orion Pharma Details
        2.6.2 Orion Pharma Major Business
        2.6.3 Orion Pharma Alzheimers and Parkinsons Diseases Product and Solutions
        2.6.4 Orion Pharma Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Orion Pharma Recent Developments and Future Plans
    2.7 UCB
        2.7.1 UCB Details
        2.7.2 UCB Major Business
        2.7.3 UCB Alzheimers and Parkinsons Diseases Product and Solutions
        2.7.4 UCB Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 UCB Recent Developments and Future Plans
    2.8 AstraZeneca
        2.8.1 AstraZeneca Details
        2.8.2 AstraZeneca Major Business
        2.8.3 AstraZeneca Alzheimers and Parkinsons Diseases Product and Solutions
        2.8.4 AstraZeneca Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 AstraZeneca Recent Developments and Future Plans
    2.9 Biogen
        2.9.1 Biogen Details
        2.9.2 Biogen Major Business
        2.9.3 Biogen Alzheimers and Parkinsons Diseases Product and Solutions
        2.9.4 Biogen Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Biogen Recent Developments and Future Plans
    2.10 Teva Pharmaceutical Industries 
        2.10.1 Teva Pharmaceutical Industries Details
        2.10.2 Teva Pharmaceutical Industries Major Business
        2.10.3 Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Product and Solutions
        2.10.4 Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
    2.11 AbbVie
        2.11.1 AbbVie Details
        2.11.2 AbbVie Major Business
        2.11.3 AbbVie Alzheimers and Parkinsons Diseases Product and Solutions
        2.11.4 AbbVie Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 AbbVie Recent Developments and Future Plans
    2.12 Vertical Pharmaceuticals
        2.12.1 Vertical Pharmaceuticals Details
        2.12.2 Vertical Pharmaceuticals Major Business
        2.12.3 Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Product and Solutions
        2.12.4 Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Vertical Pharmaceuticals Recent Developments and Future Plans
    2.13 ALLERGAN
        2.13.1 ALLERGAN Details
        2.13.2 ALLERGAN Major Business
        2.13.3 ALLERGAN Alzheimers and Parkinsons Diseases Product and Solutions
        2.13.4 ALLERGAN Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 ALLERGAN Recent Developments and Future Plans
    2.14 ACADIA Pharmaceuticals
        2.14.1 ACADIA Pharmaceuticals Details
        2.14.2 ACADIA Pharmaceuticals Major Business
        2.14.3 ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Product and Solutions
        2.14.4 ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 ACADIA Pharmaceuticals Recent Developments and Future Plans
    2.15 Impax Laboratories
        2.15.1 Impax Laboratories Details
        2.15.2 Impax Laboratories Major Business
        2.15.3 Impax Laboratories Alzheimers and Parkinsons Diseases Product and Solutions
        2.15.4 Impax Laboratories Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Impax Laboratories Recent Developments and Future Plans
    2.16 GE healthcare
        2.16.1 GE healthcare Details
        2.16.2 GE healthcare Major Business
        2.16.3 GE healthcare Alzheimers and Parkinsons Diseases Product and Solutions
        2.16.4 GE healthcare Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 GE healthcare Recent Developments and Future Plans
    2.17 VTV Therapeutics
        2.17.1 VTV Therapeutics Details
        2.17.2 VTV Therapeutics Major Business
        2.17.3 VTV Therapeutics Alzheimers and Parkinsons Diseases Product and Solutions
        2.17.4 VTV Therapeutics Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 VTV Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Alzheimers and Parkinsons Diseases Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Alzheimers and Parkinsons Diseases Players Market Share
        3.2.2 Top 10 Alzheimers and Parkinsons Diseases Players Market Share
        3.2.3 Market Competition Trend
    3.3 Alzheimers and Parkinsons Diseases Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Alzheimers and Parkinsons Diseases Revenue and Market Share by Type (2016-2021)
    4.2 Global Alzheimers and Parkinsons Diseases Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Alzheimers and Parkinsons Diseases Revenue Market Share by Application (2016-2021)
    5.2 Alzheimers and Parkinsons Diseases Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
    6.2 North America Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
    6.3 North America Alzheimers and Parkinsons Diseases Market Size by Country
        6.3.1 North America Alzheimers and Parkinsons Diseases Revenue by Country (2016-2026)
        6.3.2 United States Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        6.3.3 Canada Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        6.3.4 Mexico Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
    7.2 Europe Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
    7.3 Europe Alzheimers and Parkinsons Diseases Market Size by Country
        7.3.1 Europe Alzheimers and Parkinsons Diseases Revenue by Country (2016-2026)
        7.3.2 Germany Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        7.3.3 France Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        7.3.5 Russia Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        7.3.6 Italy Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
    8.2 Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
    8.3 Asia-Pacific Alzheimers and Parkinsons Diseases Market Size by Region
        8.3.1 Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Region (2016-2026)
        8.3.2 China Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        8.3.3 Japan Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        8.3.4 South Korea Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        8.3.5 India Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        8.3.7 Australia Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
    9.2 South America Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
    9.3 South America Alzheimers and Parkinsons Diseases Market Size by Country
        9.3.1 South America Alzheimers and Parkinsons Diseases Revenue by Country (2016-2026)
        9.3.2 Brazil Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        9.3.3 Argentina Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
    10.2 Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
    10.3 Middle East & Africa Alzheimers and Parkinsons Diseases Market Size by Country
        10.3.1 Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Country (2016-2026)
        10.3.2 Turkey Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
        10.3.4 UAE Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer